Prothena Corporation PLC PRTA.OQ PRTA.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025
The Dublin Ireland-based company is expected to report a 16,000.0% increase in revenue to $8.05 million from $50 thousand a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Prothena Corporation PLC is for a loss of 97 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Prothena Corporation PLC is $44.00, above its last closing price of $8.08.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-1.06
-1.04
-1.08
Missed
-3.6
Sep. 30 2024
-1.17
-1.18
-1.10
Beat
6.6
Jun. 30 2024
-1.02
-1.05
1.22
Beat
215.8
Mar. 31 2024
-1.20
-1.20
-1.34
Missed
-11.6
Dec. 31 2023
-1.24
-1.22
-1.26
Missed
-3.6
Sep. 30 2023
-0.35
-0.32
0.38
Beat
218
Jun. 30 2023
-1.10
-1.00
-1.03
Missed
-3.4
Mar. 31 2023
-0.98
-0.94
-0.89
Beat
5.8
This summary was machine generated May 6 at 21:05 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)